NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered ...

However, pharmaceutical companies can leverage AI to overcome challenges and streamline the clinical trial landscape. Ways AI Can Help Pharmaceutical Companies Address Common Challenges With ...

Unveiling the power of AI in patient subgroups SOMS' AI-driven subgroup analysis is transforming clinical trials through real-time data processing and continuous tracking of patient subgroups.

The potential applications of artificial intelligence (AI) in biopharmaceuticals appear wide-ranging and transformative.

Beyond Supply Chain: AI-Powered Innovations for Trial Optimization Alongside Clinical Supply Chain On Demand, Good AI and Intrinseque Health are introducing AI-powered solutions for protocol ...

The Toronto-based company, Altis Labs, claims its AI model is similarly superior at analyzing breast cancer and colorectal ...

QuantHealth, an AI-powered drug development platform trusted by the largest pharmaceutical companies, today announced registration has opened for its annual AI in Clinical Development Summit, which ...

Tempus AI, Inc. TEM recently announced the acquisition of Deep 6 AI, a leading artificial intelligence (AI) company specializing in clinical trial matching. This strategic move aims to enhance Tempus’ ...

This collaboration with Intrinseque Health allows us to introduce AI-driven logistics automation and real-time supply optimization, making clinical trial execution more predictable and cost ...